Literature DB >> 18469029

Changes in diagnosis with follow-up in an incident cohort of patients with parkinsonism.

R Caslake1, J N Moore, J C Gordon, C E Harris, C Counsell.   

Abstract

BACKGROUND: Accurate diagnosis of the cause of parkinsonism during life can be difficult, particularly at presentation, but few studies have described changes in clinical diagnosis over time and the effect of applying strict research criteria.
METHODS: Incident patients with a possible/probable diagnosis of degenerative or vascular parkinsonism had a standardised assessment at diagnosis and at yearly intervals thereafter at which the most likely clinical diagnosis was recorded without strict application of research criteria. Four years after the beginning of the incident period, formal research criteria were applied retrospectively using patient records at baseline and the latest yearly follow-up.
RESULTS: Of 82 incident patients, 66 underwent at least 1 year of follow-up. After a median follow-up of 29 months, clinical diagnosis had changed in 22 (33%). Most (82%) changes occurred in the first year and were due to the development of atypical clinical features, particularly early cognitive impairment; the results of brain imaging; responsiveness to levodopa; and the rate of disease progression. Diagnosis on research criteria differed from latest clinical diagnosis in eight participants (12%). Research criteria gave a "probable" diagnosis in 71% of parkinsonian patients at follow-up but in only 15% at the initial assessment. DISCUSSION: The clinical diagnosis of the cause of parkinsonism at presentation was often incorrect, even when made by those with a special interest. In particular, Parkinson's disease was overdiagnosed. Research criteria were often unhelpful in clarifying the diagnosis, even after a median of 29 months of follow-up. Further research is required to identify factors that may be used to improve the accuracy of diagnosis at initial assessment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18469029     DOI: 10.1136/jnnp.2008.144501

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  21 in total

1.  The impact of motor and non motor symptoms on health state values in newly diagnosed idiopathic Parkinson's disease.

Authors:  James Shearer; Colin Green; Carl E Counsell; John P Zajicek
Journal:  J Neurol       Date:  2011-08-05       Impact factor: 4.849

2.  Usefulness of quantitative susceptibility mapping for the diagnosis of Parkinson disease.

Authors:  Y Murakami; S Kakeda; K Watanabe; I Ueda; A Ogasawara; J Moriya; S Ide; K Futatsuya; T Sato; K Okada; T Uozumi; S Tsuji; T Liu; Y Wang; Y Korogi
Journal:  AJNR Am J Neuroradiol       Date:  2015-03-12       Impact factor: 3.825

Review 3.  Differentiation of atypical Parkinson syndromes.

Authors:  Günter U Höglinger; Jan Kassubek; Ilona Csoti; Reinhard Ehret; Heinz Herbst; Ingmar Wellach; Jürgen Winkler; Wolfgang H Jost
Journal:  J Neural Transm (Vienna)       Date:  2017-02-27       Impact factor: 3.575

4.  Submandibular gland needle biopsy for the diagnosis of Parkinson disease.

Authors:  Charles H Adler; Brittany N Dugger; Michael L Hinni; David G Lott; Erika Driver-Dunckley; Jose Hidalgo; Jonette Henry-Watson; Geidy Serrano; Lucia I Sue; Thomas Nagel; Amy Duffy; Holly A Shill; Haruhiko Akiyama; Douglas G Walker; Thomas G Beach
Journal:  Neurology       Date:  2014-02-05       Impact factor: 9.910

5.  Quantifying changes in nigrosomes using quantitative susceptibility mapping and neuromelanin imaging for the diagnosis of early-stage Parkinson's disease.

Authors:  Hiroto Takahashi; Yoshiyuki Watanabe; Hisashi Tanaka; Masahito Mihara; Hideki Mochizuki; Tian Liu; Yi Wang; Noriyuki Tomiyama
Journal:  Br J Radiol       Date:  2018-05-17       Impact factor: 3.039

6.  Submandibular gland biopsy for the diagnosis of Parkinson disease.

Authors:  Thomas G Beach; Charles H Adler; Brittany N Dugger; Geidy Serrano; Jose Hidalgo; Jonette Henry-Watson; Holly A Shill; Lucia I Sue; Marwan N Sabbagh; Haruhiko Akiyama
Journal:  J Neuropathol Exp Neurol       Date:  2013-02       Impact factor: 3.685

7.  Parkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and Diagnosis.

Authors:  George DeMaagd; Ashok Philip
Journal:  P T       Date:  2015-08

8.  Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.

Authors:  Naying He; Huawei Ling; Bei Ding; Juan Huang; Yong Zhang; Zhongping Zhang; Chunlei Liu; Kemin Chen; Fuhua Yan
Journal:  Hum Brain Mapp       Date:  2015-08-07       Impact factor: 5.038

9.  Parkinson's disease: diagnostic potential of high-resolution phase difference enhanced MR imaging at 3 T.

Authors:  Shingo Kakeda; Yukunori Korogi; Tetsuya Yoneda; Keita Watanabe; Junji Moriya; Yu Murakami; Toru Sato; Yasuhiro Hiai; Norihiro Ohnari; Satoru Ide; Kazumasa Okada; Takenori Uozumi; Sadatoshi Tsuji; Toshinori Hirai; Yasuyuki Yamashita
Journal:  Eur Radiol       Date:  2012-10-19       Impact factor: 5.315

10.  Detecting new neurodegenerative disease genes: does phenotype accuracy limit the horizon?

Authors:  David C Samuels; David J Burn; Patrick F Chinnery
Journal:  Trends Genet       Date:  2009-10-12       Impact factor: 11.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.